CONDITION
Pancreatitis in Cats
An inflammatory condition of the pancreas in cats that often presents subtly, may occur alongside other organ conditions, and can be life-threatening in its severe acute form.
Why this matters now
Pancreatitis in cats can occur at any age, and no age, sex or breed predisposition is recognised. Unlike canine pancreatitis, where dietary indiscretion is a recognised risk factor, feline pancreatitis frequently develops without a clearly identifiable precipitating cause, making it a particularly insidious condition. The condition has historically been underdiagnosed in cats due to its often subtle and non-specific clinical presentation, which can differ substantially from the more dramatic signs typically seen in dogs. Advances in diagnostic capabilities, particularly the development of feline-specific pancreatic lipase immunoreactivity (fPLI) testing, have improved recognition of this condition and revealed it to be considerably more common than previously appreciated.
Feline pancreatitis can present across a spectrum from mild, self-limiting episodes to severe, life-threatening acute disease, with many cats experiencing a chronic or recurrent pattern. Acute pancreatitis may develop rapidly and can produce significant systemic effects, though even acute episodes in cats tend to present with less dramatic signs than in dogs. Published mortality rates for acute pancreatitis in cats range from 9% to 41%, and the longer a cat has shown signs before reaching a hospital, the higher the odds of death. Chronic pancreatitis, characterised by persistent low-grade inflammation and progressive fibrosis of the pancreatic tissue, is particularly common in cats and may smoulder for extended periods with subtle, intermittent signs that are easily overlooked. A significant proportion of cats with pancreatitis have concurrent inflammatory conditions affecting the liver (cholangitis) and intestines (inflammatory bowel disease), a constellation sometimes referred to as 'triaditis,' which reflects the anatomical proximity and shared inflammatory pathways among these organs in the feline abdomen. Over time, chronic pancreatitis may eventually compromise the endocrine function of the pancreas sufficiently to contribute to the development of diabetes mellitus.
Signals & patterns
Early signals
Decreased appetite or food refusal
A reduction in appetite (ranging from eating less than usual to complete food refusal) is one of the most commonly observed signs of pancreatitis in cats. The change may be subtle, with the cat eating more slowly, leaving food, or showing increased selectivity. In a species where reduced appetite can have serious metabolic consequences (particularly hepatic lipidosis), even mild inappetence warrants attention, especially when it persists beyond a day or two.
Lethargy and withdrawal
Cats with pancreatitis often become quieter, less interactive, and more inclined to seek out secluded resting spots. They may show reduced interest in their surroundings, decreased play behaviour, and less responsiveness to social contact. Because cats naturally spend significant time resting, distinguishing pathological lethargy from normal behaviour can be challenging, but a noticeable change from the individual cat's baseline is significant.
Subtle changes in posture or movement
Abdominal discomfort may manifest as a hunched posture, reluctance to be handled around the abdomen, or slight changes in movement quality. Unlike dogs, cats with pancreatitis rarely show the dramatic abdominal pain behaviours (prayer posture, vocalisation) that can make the condition more readily recognisable. Some cats may show a preference for positions that avoid pressure on the abdomen, such as sitting in a sphinx-like posture rather than lying on their side.
Mild vomiting or nausea
While vomiting is a prominent feature of canine pancreatitis, it occurs less consistently in cats, and when present may be infrequent or mild. Signs of nausea without overt vomiting (such as lip licking, drooling, turning away from food, or brief episodes of retching) may be the primary gastrointestinal signs observed. These subtle indicators of nausea can be easily overlooked in a species that may naturally be less demonstrative when unwell.
Mild dehydration
Reduced food and water intake combined with the inflammatory process can lead to mild dehydration, which may show as slightly tacky gums or skin that is slow to return to its normal position when gently tented. In mild cases, the dehydration may not be obvious at home, yet dehydration is found on examination in 37% to 92% of cats with pancreatitis and contributes to the cat's general sense of unwellness.
Later signals
Persistent inappetence and weight loss
Sustained food refusal is a significant concern in cats, particularly overweight cats, because hepatic lipidosis can develop after a period without food that may be as short as 2 to 7 days, and its presence substantially increases mortality. Progressive weight loss may occur in cats with chronic or recurrent pancreatitis as cumulative periods of reduced intake and impaired nutrient absorption take their toll. The weight loss may be gradual and not apparent at first, particularly in cats with a generous initial body condition.
Jaundice (icterus)
A yellowish discolouration of the skin, gums, and the whites of the eyes may develop if pancreatic inflammation extends to or compresses the common bile duct, impeding the flow of bile from the liver. Jaundice may also indicate concurrent cholangitis or hepatic involvement. This is not a mild sign: in a retrospective study of 142 hospitalised cats with pancreatitis, jaundice was independently associated with death (odds ratio 4.6). Its cause cannot be judged from appearance and is established through blood tests and imaging.
Hypothermia
Unlike many inflammatory conditions that produce fever, cats with pancreatitis may develop low body temperature (hypothermia), which is recorded in 39% to 68% of affected cats, compared with fever in 7% to 26%. A cold cat that is also lethargic and inappetent is showing signs that the illness is affecting the whole body, although one retrospective study of 142 hospitalised cats with pancreatitis did not find a low body temperature linked to death.
Signs of concurrent triaditis
When pancreatitis occurs alongside cholangitis and inflammatory bowel disease, the clinical picture may include a combination of gastrointestinal signs (diarrhoea, vomiting), hepatic signs (jaundice, abnormal liver enzymes), and the general signs of pancreatitis. The overlapping symptomatology of these three conditions can create a complex clinical picture that reflects the multi-organ nature of the inflammatory process. Identifying the full extent of organ involvement is important for comprehensive management.
Click to read about the biological mechanisms
How this is usually investigated
Investigating suspected pancreatitis in cats can be challenging due to the often non-specific nature of the clinical signs and the limitations of individual diagnostic tests. A combination of clinical findings, laboratory assessments, and imaging is typically used to build a composite picture, as no single test confirms the diagnosis in every case. The investigation also aims to identify concurrent conditions, particularly hepatobiliary disease and inflammatory bowel disease, which frequently accompany feline pancreatitis.
Feline pancreatic lipase immunoreactivity (fPLI/Spec fPL)
Abdominal ultrasonography
Blood biochemistry and haematology
Cobalamin and folate levels
Pancreatic biopsy (surgical or laparoscopic)
Options & trade-offs
Management of pancreatitis in cats focuses on supportive care, pain management, nutritional support, and addressing concurrent conditions. The approach to nutrition in affected cats differs from that in dogs in important ways. The management strategy is typically tailored to the severity and chronicity of the disease, with acute episodes often requiring more intensive support.
Fluid therapy and electrolyte correction
Intravenous or subcutaneous fluid therapy addresses dehydration, supports renal perfusion, and helps correct electrolyte imbalances that may develop through reduced intake and vomiting. In acute or severe cases, intravenous fluid therapy is typically administered in a hospital setting with careful monitoring. For cats with milder presentations or chronic disease, subcutaneous fluid supplementation may be provided as part of outpatient management.
Trade-offs: Intravenous fluid therapy requires hospitalisation and venous catheter placement, which can be stressful for cats. Careful monitoring is needed to avoid fluid overload, particularly in cats with concurrent cardiac disease. The duration and intensity of fluid therapy depend on the severity of dehydration and the cat's ongoing losses and intake.
Pain management
Recognising and treating pain is an important part of feline pancreatitis management, even though cats may not display obvious pain behaviours. Opioids are the main analgesics used. Buprenorphine is UK-authorised for cats as an injection for post-operative pain, so its use for pancreatitis, and giving it onto the gums (transmucosally), is off-licence. Gabapentin, a human medicine prescribed under the veterinary medicines cascade, may be added as an oral option. Non-steroidal anti-inflammatory drugs are not among the analgesics recommended in the published consensus guidance for feline pancreatitis: the UK datasheet for meloxicam in cats advises against use in any dehydrated animal because of the risk of kidney damage, and cats with pancreatitis are often dehydrated. Effective pain management can improve appetite, reduce stress, and support recovery.
Trade-offs: Assessing pain in cats is inherently challenging, and the absence of obvious pain behaviours does not indicate the absence of pain. Some analgesic agents may cause sedation, which can be difficult to distinguish from disease-related lethargy. The choice of analgesic depends on the individual cat's overall health status, particularly renal function and hydration status.
Nutritional support and early feeding
Current understanding favours early nutritional support in cats with pancreatitis, in contrast to the traditional approach of withholding food. Maintaining nutritional intake helps prevent hepatic lipidosis, supports intestinal barrier function, and provides the nutrients needed for tissue healing. If the cat will not eat voluntarily, an appetite stimulant or feeding tube placement may be considered. Mirtazapine is UK-authorised for cats as a transdermal ointment, for weight gain in cats with poor appetite and weight loss resulting from chronic medical conditions, so use in a short, acute illness is off-licence. Published consensus guidance is that a feeding tube is indicated when a cat has not responded to appetite stimulants within 48 hours, or has already gone without food for a prolonged period before being seen. The diet does not need to be specifically low-fat, as dietary fat restriction has not been shown to be as important in feline pancreatitis as it may be in dogs.
Trade-offs: Syringe feeding can be stressful for cats, and severely ill cats are prone to food aversion, which is one reason a feeding tube is often preferred. An oesophagostomy tube requires general anaesthesia to place, whereas a naso-oesophageal tube can be placed under local anaesthesia but allows only a liquid diet. Either can provide a reliable route for nutrition, medication, and hydration. The decision to place a feeding tube involves balancing the benefits of reliable nutritional support against the procedural requirements and the individual cat's tolerance.
Anti-nausea medication
Anti-emetic and anti-nausea medications such as maropitant and ondansetron can help control vomiting and reduce the nausea that contributes to inappetence. Addressing nausea is often an important step in restoring voluntary food intake. These medications may be given by injection during initial treatment and changed to oral forms as the cat improves. Maropitant injection is UK-authorised for cats, but maropitant tablets are authorised for dogs only, so their use in cats is off-licence. Ondansetron is a human medicine prescribed under the veterinary medicines cascade.
Trade-offs: Anti-nausea medications address the symptom rather than the underlying cause of the nausea. Some cats may require multiple agents to achieve adequate nausea control. Long-term use may be needed in cats with chronic or recurrent pancreatitis, and the cost and practicality of ongoing medication administration are practical considerations.
Management of concurrent conditions
When pancreatitis occurs as part of a triaditis complex, the concurrent cholangitis and inflammatory bowel disease also need to be managed for the cat to improve overall. This may include antibiotics for suspected bacterial cholangitis, immunomodulatory medications such as prednisolone (UK-authorised for cats) for the inflammatory bowel component, ursodeoxycholic acid (a human medicine prescribed under the veterinary medicines cascade) to support bile flow, and cobalamin (vitamin B12) where a low level has been documented. The single-ingredient vitamin B12 injections authorised in the UK are for farm animals and horses, not cats, so injections are given under the veterinary medicines cascade, and oral products are sold as supplements. Addressing diabetes mellitus, if it has developed secondary to pancreatic damage, adds an additional layer to the management plan.
Trade-offs: Managing multiple concurrent conditions increases the complexity of the treatment plan, the number of medications, and the monitoring requirements. Some treatments for one component (such as corticosteroids for IBD) may potentially influence another component (such as glucose regulation in a cat with developing diabetes). Balancing the needs of multiple organ systems requires careful coordination and regular reassessment.
Common misconceptions
"If a cat is not vomiting dramatically, it cannot have pancreatitis"
Feline pancreatitis often presents with far more subtle signs than its canine counterpart, and many cats with confirmed pancreatitis do not vomit at all. The most common signs in cats are non-specific (reduced appetite, lethargy, and withdrawal) and can be easily attributed to other causes or overlooked entirely. The absence of dramatic gastrointestinal signs does not exclude pancreatitis, and the subtlety of feline clinical presentations is a major reason the condition has been historically underdiagnosed.
"Pancreatitis in cats is always caused by a high-fat diet"
Unlike in dogs, where dietary indiscretion and high-fat meals are recognised triggers, the cause of pancreatitis in cats is frequently idiopathic, meaning no specific trigger can be identified. Whilst various factors including infections, trauma, certain medications, and other inflammatory conditions have been associated with feline pancreatitis, in many cases the initiating cause remains unknown. Dietary fat restriction has not been demonstrated to be as important in preventing or managing feline pancreatitis as it may be in canine cases.
"Pancreatitis is always an acute, one-time event"
In cats, chronic pancreatitis (characterised by persistent, low-grade inflammation and progressive fibrosis) may be more common than acute pancreatitis. The chronic form can persist for months or years with subtle, waxing and waning signs that may go unrecognised. Additionally, cats may experience recurrent acute episodes, and the distinction between acute and chronic forms is not always clear-cut on clinical presentation alone. The chronic nature of feline pancreatitis means that ongoing awareness and monitoring, rather than single-episode management, is often appropriate.
Related conditions
Inflammatory Bowel Disease in Cats
Inflammatory bowel disease and pancreatitis in cats often occur together as part of a condition sometimes called triaditis, which also involves the liver and bile ducts. Cats presenting with signs of one may have subclinical inflammation in the other organs.
Chronic Kidney Disease in Cats
Chronic kidney disease and pancreatitis can coexist in older cats, and each may complicate the clinical picture of the other. In severe acute pancreatitis, acute kidney injury can develop as a result of poor circulation and reduced oxygen delivery to the kidneys.
Diabetes Mellitus in Cats
Diabetes mellitus can develop following episodes of pancreatitis if the inflammatory process damages the insulin-producing cells within the pancreas. In some cases, concurrent inflammation and metabolic disruption may make distinguishing the primary driver difficult.
Pancreatitis in Dogs
Pancreatitis in dogs and cats shares similar underlying mechanisms of pancreatic inflammation, though the clinical presentation tends to be more subtle in cats. Understanding the condition across species can help owners recognise patterns, though management approaches may differ.
Exocrine Pancreatic Insufficiency (EPI)
Exocrine pancreatic insufficiency represents a loss of digestive enzyme production from the pancreas, whereas pancreatitis involves inflammation of the organ. In some cases, repeated or severe pancreatic inflammation may eventually lead to loss of functional tissue and enzyme deficiency.
Understanding feline pancreatitis as a condition that can present subtly and often coexists with other inflammatory conditions can help frame the importance of attentive observation of changes in a cat's eating behaviour, energy levels, and general demeanour. Cats with a history of pancreatitis may be at risk of recurrent episodes, and awareness of the signs, however subtle, can support earlier recognition. The relationship between pancreatic health, liver function, and intestinal integrity in cats is an area of active veterinary research, and understanding of the interconnected inflammatory processes continues to develop. Many cats with mild or chronic pancreatitis can maintain good quality of life with appropriate management and monitoring, whereas the outlook in severe acute pancreatitis is guarded.
Last reviewed: 9 October 2026 · Dr Alastair Greenway MRCVS